Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Preferred Shares (2016)

Historic Preferred Shares for Perspective Therapeutics (CATX) over the last 6 years, with Q1 2016 value amounting to $59.0.

  • Perspective Therapeutics' Preferred Shares changed N/A to $59.0 in Q1 2016 from the same period last year, while for Mar 2016 it was $59.0, marking a year-over-year change of. This contributed to the annual value of $59.0 for FY2015, which is 0.0% changed from last year.
  • Per Perspective Therapeutics' latest filing, its Preferred Shares stood at $59.0 for Q1 2016.
  • Over the past 5 years, Perspective Therapeutics' Preferred Shares peaked at $61.0 during Q3 2013, and registered a low of $59.0 during Q1 2012.
  • Over the past 5 years, Perspective Therapeutics' median Preferred Shares value was $59.0 (recorded in 2012), while the average stood at $59.31.
  • Its Preferred Shares has fluctuated over the past 5 years, first changed by 0.0% in 2012, then skyrocketed by 338.98% in 2013.
  • Quarter analysis of 5 years shows Perspective Therapeutics' Preferred Shares stood at $59.0 in 2012, then increased by 3.39% to $61.0 in 2013, then dropped by 3.28% to $59.0 in 2014, then changed by 0.0% to $59.0 in 2015, then changed by 0.0% to $59.0 in 2016.
  • Its Preferred Shares stands at $59.0 for Q1 2016, versus $59.0 for Q4 2015 and $59.0 for Q2 2015.